Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003316,
umls-concept:C0017082,
umls-concept:C0042776,
umls-concept:C0184511,
umls-concept:C0597357,
umls-concept:C0678594,
umls-concept:C0680730,
umls-concept:C1145667,
umls-concept:C1148554,
umls-concept:C1167622,
umls-concept:C1440044,
umls-concept:C1510438,
umls-concept:C1524075,
umls-concept:C2076600
|
pubmed:issue |
1
|
pubmed:dateCreated |
1992-7-16
|
pubmed:abstractText |
An improved binding assay for detection of ganglioside receptors for influenza A, B, and C viruses was developed. In this system, the virions bound to gangliosides that were developed on a silica gel thin-layer plate were detected by mouse monoclonal antibody against viral hemagglutinin and peroxidase-conjugated anti-mouse immunoglobin. No hydrolysis of the gangliosides by viral receptor-destroying enzyme was detected in the present condition. The reactivity of the viruses to gangliosides depended on the amount of developed gangliosides (10 pmols-10 nmols), the molecular species of sialic acid, and their sugar sequences. Human influenza A (PR/8/34), B (Lee/40), and C (Ann Arbor/1/50) viruses bound different receptor epitopes of sialo-sugar chains of gangliosides. The A/PR/8 virus bound most effectively to Neu5Ac-containing lacto-series gangliosides carrying type I and type II sugar chains, followed by ganglio-series and hematoside-series gangliosides. The A/PR/8 virus weakly bound to Neu5Ac alpha 2,6lactotetraosylceramide [IV6(Neu5Ac)Lc4Cer] and Neu5Ac alpha 2,6paragloboside [IV6(Neu5Ac)nLc4Cer] carrying Neu5Ac alpha 2,6Gal sequence, although their Neu5Ac alpha 2,3Gal derivatives were the most potent gangliosides tested. B/Lee/40 bound restrictively to IV6(Neu5Ac)Lc4Cer and IV6(Neu5Ac)nLc4Cer, which carry Neu5Ac alpha 2,6Gal sequence, and type I and type II lacto-series sugar chain, respectively. C/Ann Arbor/1/50 reacted only with 9-O-Ac-Neu5Ac-carrying sugar chains in all the gangliosides tested. This method also allowed the microanalysis of receptor gangliosides of unknown samples. ESK cells, sensitive to the influenza A viruses infection, expressed several kinds of receptor active gangliosides, while those from ESK-R cells, resistant to the virus infection, were undetectable.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes,
http://linkedlifedata.com/resource/pubmed/chemical/Gangliosides,
http://linkedlifedata.com/resource/pubmed/chemical/Globosides,
http://linkedlifedata.com/resource/pubmed/chemical/Oligosaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Virus,
http://linkedlifedata.com/resource/pubmed/chemical/sialooligosaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/sialosylparagloboside
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0042-6822
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
189
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
121-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1376537-Binding Sites,
pubmed-meshheading:1376537-Carbohydrate Sequence,
pubmed-meshheading:1376537-Epitopes,
pubmed-meshheading:1376537-Gangliosides,
pubmed-meshheading:1376537-Globosides,
pubmed-meshheading:1376537-Immunologic Techniques,
pubmed-meshheading:1376537-Influenza A virus,
pubmed-meshheading:1376537-Influenza B virus,
pubmed-meshheading:1376537-Influenzavirus C,
pubmed-meshheading:1376537-Molecular Sequence Data,
pubmed-meshheading:1376537-Oligosaccharides,
pubmed-meshheading:1376537-Orthomyxoviridae,
pubmed-meshheading:1376537-Receptors, Virus,
pubmed-meshheading:1376537-Sensitivity and Specificity,
pubmed-meshheading:1376537-Virology
|
pubmed:year |
1992
|
pubmed:articleTitle |
Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains.
|
pubmed:affiliation |
Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Science, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|